Zobrazeno 1 - 10
of 226
pro vyhledávání: '"W H, Birkenhäger"'
Autor:
Dickinson, C. J.
Publikováno v:
The British Medical Journal, 1977 Feb 01. 1(6057), 392-392.
Externí odkaz:
https://www.jstor.org/stable/20413231
Autor:
H. Haenel
Publikováno v:
Food / Nahrung. 30:1060-1060
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f2244649077019d4fe1d88a3f690f83
https://doi.org/10.1002/food.19860301038
https://doi.org/10.1002/food.19860301038
Publikováno v:
Acta Medica Scandinavica. 202:389-392
The effect of propranolol on diurnal variability of BP and plasma noradrenaline levels was assessed in 15 patients with uncomplicated essential hypertension. While total variability and average noradrenaline level remained unaltered, the pressor rang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccaa76e1726af326815eb28ff33939f7
https://doi.org/10.1111/j.0954-6820.1977.tb16849.x
https://doi.org/10.1111/j.0954-6820.1977.tb16849.x
Publikováno v:
Seminars in Cerebrovascular Diseases and Stroke. 3:155-164
Hypertension is the most consistent and powerful predictor of stroke and is involved in nearly 70% of strokes. Placebo-controlled trials have proven that blood-pressure-lowering treatment reduces the incidence of stroke by 40% in middle-aged or older
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3787fe5d7587b4cf7b3dd9558566b44
https://doi.org/10.1053/j.scds.2003.00.025
https://doi.org/10.1053/j.scds.2003.00.025
Autor:
Jan A. Staessen, W. H. Birkenhäger
Publikováno v:
Current Hypertension Reports. 1:225-231
This review attempts to highlight the potential of calcium-channel blockers in the prevention of sequelae of diabetes mellitus and hypertension in patients who have both disorders. Evidence-based medicine is driven by the results of randomized, clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df0b99325c65f86cab7ced4f15790e1c
https://doi.org/10.1007/s11906-999-0025-6
https://doi.org/10.1007/s11906-999-0025-6
Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress
Autor:
C Nachev, P. W. De Leeuw, Lutgarde Thijs, Y Yodfat, A E Fletcher, Christopher J. Bulpitt, M. Safar, K Kawecka-Jaszcz, J Webster, Robert Fagard, J Rosenfeld, GG Arabidze, Hilde Celis, Jan A. Staessen, J Duggan, J Tuomilehto, Jerzy Gasowski, W. H. Birkenhäger, JL Rodicio, M.-L. Seux, CT Dollery, G Leonetti
Publikováno v:
Journal of Human Hypertension. 13:135-145
The Systolic Hypertension in Europe (Syst-Eur) trial proved that blood pressure (BP) lowering therapy starting with nitrendipine reduces the risk of cardiovascular complications in older (> or = 60 years) patients with isolated systolic hypertension
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0285ef6762d988f3c56c5cecd99ed9b8
https://doi.org/10.1038/sj.jhh.1000769
https://doi.org/10.1038/sj.jhh.1000769
Publikováno v:
European Heart Journal. 20:11-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8deb5e442cf7a7491151c38336bd25e
https://doi.org/10.1053/euhj.1998.1121
https://doi.org/10.1053/euhj.1998.1121
Autor:
W. H. Birkenhäger, Jan A. Staessen
Publikováno v:
The Lancet. 366:869-871
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b897c9338b46566db3c1cd152e9d49
https://doi.org/10.1016/s0140-6736(05)67147-4
https://doi.org/10.1016/s0140-6736(05)67147-4
Publikováno v:
Hypertension. 57
To the Editor: Hypertension at middle age is a risk factor for vascular and neurodegenerative dementia later in life.1 Because populations are aging, the number of demented patients will grow 2-fold every 20 years, from 24.3 million people in 2000 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8888d6ed4e6e52a6ec6411ea974055c9
https://doi.org/10.1161/hypertensionaha.110.165142
https://doi.org/10.1161/hypertensionaha.110.165142